New drug law gives AG power to ban substances without court review

What it does

This bill creates a new 'Schedule A' category in the Controlled Substances Act to regulate synthetic drug analogues—chemical variants of illegal drugs designed to evade existing laws. The Attorney General gains power to temporarily ban substances for up to 5 years (with 30-day notice) and then make permanent bans, based on chemical similarity and predicted effects. Violations carry up to 20 years imprisonment (30 years if there's a prior drug conviction, or life if death results), plus mandatory supervised release and fines up to $1–5 million. The bill also requires proper chemical labeling of Schedule A substances and allows researchers to continue work on newly scheduled drugs under certain conditions.

Why we flagged it

The bill's core mechanism is creating a new regulatory schedule and enforcement authority for synthetic drug analogues. While framed as a public-health measure, it is fundamentally an expansion of executive power to criminalize substances with minimal procedural safeguards and severe mandatory penalties.

What the text implies

• The 'predicted' effect standard (based on chemical structure, structure-activity relationships, or binding assays) is subjective and may allow the Attorney General to schedule substances without empirical evidence of actual abuse or harm, potentially capturing legitimate research chemicals or industrial compounds.
• Temporary scheduling orders are explicitly exempt from judicial review (Section 3(4)), meaning defendants cannot challenge the legality of a ban in court before prosecution—a significant due-process gap compared to other CSA schedules.
• Mandatory minimum sentences (20–30 years, or life if death results) apply to all Schedule A violations regardless of quantity, intent, or role, removing judicial discretion and potentially creating disproportionate sentences for minor importation or possession offenses.
• Researchers conducting work on a substance at the time it is scheduled to Schedule A must reapply for registration within 30 days or face criminal liability, creating operational disruption and potential chilling effects on legitimate pharmacological and toxicology research.
• The bill allows the Attorney General to extend temporary scheduling orders by 180 days during permanent scheduling proceedings, potentially keeping a substance banned indefinitely while the AG delays final rulemaking.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill addresses a genuine public-health problem—synthetic drug analogues that circumvent existing law—and creates a faster regulatory pathway than current procedures. However, it grants the Attorney General broad power to ban substances with minimal judicial review (temporary orders are not reviewable), creates severe mandatory penalties that may not fit all offenses, and relies on 'predicted' effects that could be applied expansively, raising due-process concerns for defendants and legitimat

Named in the bill

Attorney General, Secretary of Health and Human Services, Controlled Substances Act, Controlled Substances Import and Export Act, Federal Food, Drug, and Cosmetic Act, International Union of Pure and Applied Chemistry (IUPAC), Single Convention on Narcotic Drugs, 1961

Where it stands

4 cosponsors: 2 Democrats, 2 Republicans.

• Nov 20, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Nov 20, 2025 — Referred to Senate Committee on the Judiciary · Congress.gov: “Read twice and referred to the Committee on the Judiciary”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.